Pozzi Forceps in Intrauterine Insemination
Randomized Control Study on the Impact of a Pozzi Tenaculum Forceps Use on the Success Rate of Intrauterine Insemination (IUI)
1 other identifier
interventional
800
1 country
1
Brief Summary
Many infertility and subfertility issues are treated nowadays with intrauterine inseminations. This is a minimally invasive technique that consists in placing sperm into a woman's uterus. Inseminations have only a fair success rate despite advances in technology ( 7 % per cycle). The goal of this study is to find an easy intervention that could help with success rate. Some studies are showing that the use of Pozzi tenaculum forceps might increase rates of pregnancy following intrauterine inseminations. In order to study the impact of this intervention, we are conducting a randomized controlled trial comparing the rate of term live births after IUI between patients who had their treatment done with a pozzi tenaculum forceps and those who had their treatment done without a tenaculum forceps.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2018
CompletedFirst Posted
Study publicly available on registry
February 19, 2018
CompletedStudy Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedFebruary 5, 2021
February 1, 2021
3.3 years
February 3, 2018
February 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of live births
Live born delivery resulting from an intrauterine insemination cycle
10 months after positive pregnancy test
Secondary Outcomes (3)
Clinical rate of pregnancy (urinary or blood b-hcG)
At the end of 1 cycle (approximately 28 days)
Patients' global satisfaction assessed by questionnaire
15 minutes after the intervention
Pain Level on visual analog scale
15 minutes after the intervention
Study Arms (2)
Pozzi for intrauterine insemination
ACTIVE COMPARATORTreatment done with a pozzi tenaculum forceps
No Pozzi for intrauterine insemination
ACTIVE COMPARATORTreatment done without a tenaculum forceps
Interventions
Obligatory use of a Pozzi forceps tenaculum during intrauterine insemination
Eligibility Criteria
You may qualify if:
- Infertility :Defined as no pregnancy after one year of regular unprotected vaginal intercourse
- Infertility secondary to endometriosis, to a mild to moderate male factor, to an ovulatory dysfunction, an unexplained infertility or any other known medical indication for IUI.
- Intrauterine insemination with a partner's semen sample or a donor sample
- First IUI treatment or first treatment since last pregnancy
- Ovulation induction with letrozole medication
- Being able to speak and understand French
You may not qualify if:
- Bilateral tubal occlusion
- Active pelvic infection
- \< 1 X 10\^6 mobile sperm on semen analysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHUL Centre Mère Enfant Soleil - CHU de Quebec
Québec, Quebec, G1V 4G2, Canada
Related Publications (1)
Dufour S, Viau M, Cote M, Lefebvre J, Maheux-Lacroix S, Bergeron ME. Impact of a Pozzi tenaculum forceps use on the success rate of intrauterine insemination (IUI) : protocol for a randomised control trial. BMJ Open. 2021 Mar 18;11(3):e043230. doi: 10.1136/bmjopen-2020-043230.
PMID: 33737427DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Eve Bergeron, MD
CHUL (CHUdeQuebec) - Département d'endocrinologie de la reproduction
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2018
First Posted
February 19, 2018
Study Start
June 1, 2019
Primary Completion
October 1, 2022
Study Completion
January 1, 2023
Last Updated
February 5, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share